Know Cancer

or
forgot password

Endothelial Function, Arterial Stiffness and Components of Metabolic Syndrome in Acute Lymphoblastic Leukemia (ALL) Survivors


N/A
8 Years
28 Years
Not Enrolling
Both
Acute Lymphoblastic Leukemia

Thank you

Trial Information

Endothelial Function, Arterial Stiffness and Components of Metabolic Syndrome in Acute Lymphoblastic Leukemia (ALL) Survivors


Inclusion Criteria:



Survivor:

Inclusion

1. Ages 8-28 (8 is chosen as lower age limit because developmental understanding will
allow survivor to follow instructions for procedures, 28 is chosen as upper limit to
include age ranges seen for treatment in the pediatric program)

2. Off therapy for at least 6 months and not more than 10 years (6 months

Inclusion

1. Biological sibling

2. Ages 8-28 (when more than one sibling is available the one closest in age will be
chosen.))

Exclusion Criteria:

1. Uncontrolled medical conditions that could interfere with participation or
interpretation of results

2. History of relapsed ALL or history of bone marrow transplantation

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Outcome Measure:

measure of endothelial

Outcome Time Frame:

at enrollment

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

J1064

NCT ID:

NCT01439217

Start Date:

June 2011

Completion Date:

February 2013

Related Keywords:

  • Acute Lymphoblastic Leukemia
  • Acute lymphoblastic leukemia
  • Survivor
  • Sibling control
  • Leukemia
  • Leukemia, Lymphoid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Name

Location

Sidney Kimmel Comprehensive Cancer CenterLutherville, Maryland  
Johns Hopkins HospitalBaltimore, Maryland  21287